Alphamab Oncology Presented Multiple Clinical Data of Anti-HER2 Biparatopic ADC JSKN003 at the 2025 ASCO Annual Meeting
SUZHOU, China, June 3, 2025 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK) announced that multiple clinical…
SUZHOU, China, June 3, 2025 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK) announced that multiple clinical…
Recognized for the Strength of its AI-Driven NDR Platform, Vectra AI is Positioned Furthest for Completeness of Vision an…
KUNSHAN, China, June 3, 2025 /PRNewswire/ — Arctech, a global leader in solar structure and tracker solutions with …
SYDNEY, June 3, 2025 /PRNewswire/ — Kalkine Australia recently launched its "The Funds Report", a researc…
TAIPEI, June 3, 2025 /PRNewswire/ — TPIsoftware‘s conversational AI product SysTalk.ai was named Best Solutio…
TAIPEI, June 3, 2025 /PRNewswire/ — TPIsoftware‘s conversational AI product SysTalk.ai was named Best So…
SHANGHAI, June 3, 2025/PRNewswire/ — Organized by Sinoexpo Informa Markets, ProPak China 2025, the premier trade fa…